Healthy
Conditions
Keywords
Red Grapes, polyphenols, cyclists, resveratrol, aerobic fitness, trained
Brief summary
This is a 3-arm double blind placebo controlled study to investigate the effect of Red Grape Cell (RGC) powder containing all the matrix of polyphenols that can be found in red grapes. polyphenols have several beneficial effects on various body systems, are present in many edible foods, and are considered safe for human consumption by regulatory authorities. Animal and human studies suggest a potential for polyphenol-rich compounds in enhancing mitochondrial activity and exercise capacity. However, the effect of RGC on exercise performance in humans had not yet been tested. A special population where increasing performance is highly sought are competitive athletes. The aim of the current study is to investigate the effect of RGC on measures of aerobic fitness, body composition and mood in trained male cyclists
Interventions
DIETARY_SUPPLEMENTRGC
DIETARY_SUPPLEMENTPlacebo
Sponsors
Fruitura Bioscience Ltd.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Age 18 - 65 years, men only * Active in cycling training group * Willingness to avoid regular use of NSAIDS (Advil, Nurofen, etc.) and aspirin for the entire study period * Without a history or evidence of significant cardiovascular, hepatic, renal, respiratory, hematopoietic, gastrointestinal disease, endocrine, metabolic, psychiatric or psychological disorders; * Willingness to avoid regular ingestion of any foods containing peanuts, bilberries, blueberries, cranberries, strawberries, raspberries, grapes, grape juice, cocoa powder, dark chocolate, red wine, over-the-counter medications, herbs, or supplements throughout the entire study, and to record and report any occasional consumption of such substances
Exclusion criteria
* Any acute medical situation (e.g., acute infection, nausea and vomiting, diarrhea) 48 hours prior to initiation of the study, which is considered of significance by the principal investigator. * Any known chronic medical condition (will be determined by the principal investigator) * History or evidence of alcohol or drug abuse * Any gastrointestinal surgery other than appendectomy or herniotomy; * Current use of over the counter or prescription weight loss medication * Current use or within the last 30 days, any cholesterol lowering medications (statins, fibrates, red yeast rice, niacin). * Known allergy to casein and/or soy. * Subjects who had participated in a drug trial 3 months before initiation of the study; * Non-cooperative subjects or unwilling to sign an informed consent and participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| changes in aerobic fitness | baseline and 6 weeks |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in mood | baseline and 6 weeks | — |
| Changes in Body Mass Index (BMI) | baseline and 6 weeks | — |
| Changes in body weight | baseline and 6 weeks | — |
| Changes in body composition | baseline and 6 weeks | changes in body fat percentage |
Other
| Measure | Time frame |
|---|---|
| Number of adverse events | 6 weeks |
Countries
Israel
Outcome results
None listed